Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FAVYU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,387
Award facts
- Contract value 100% obligated
- $10,386.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,386.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for AIMOVIG 140 mg/ml autoinjectors. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, carries no set-aside designation. Performance will occur in Conshohocken, Pennsylvania. AIMOVIG (erenumab) is a monoclonal antibody used for migraine prevention, and this delivery order represents a specific product fulfillment under DMS Pharmaceutical Group's existing contract vehicle with the Defense Logistics Agency.
This delivery order is issued under the broader context of DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies supporting military health facility needs worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's federal contracting history demonstrates a robust portfolio of pharmaceutical product deliveries, positioning it as a reliable vendor for specialized pharmaceutical items such as auto-injectors and injectable medications.
Quick answers
Who was awarded contract SPE2DB25FAVYU?
SPE2DB25FAVYU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FAVYU worth?
The government has obligated $10,387 on SPE2DB25FAVYU.
Is contract SPE2DB25FAVYU an order under another contract?
Yes. SPE2DB25FAVYU is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVYU competed?
The extent of competition for SPE2DB25FAVYU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award